Opioid vs Non-Opioid Pain Management for Supracondylar Humerus Fractures
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to manage pain after surgery for a specific upper arm fracture near the elbow, known as a Gartland Type III Supracondylar Humerus Fracture. Researchers compare the effectiveness of non-opioid painkillers, such as acetaminophen and ibuprofen, with opioid painkillers, like hydrocodone combined with acetaminophen. The goal is to determine which option provides better pain relief after surgery. Children who have experienced this fracture and meet certain criteria, such as treatment at Children's Mercy Hospital and the absence of other major injuries or medical conditions, may be suitable candidates for this trial. As a Phase 4 trial, the research involves treatments already FDA-approved and proven effective, aiming to understand how they benefit more patients.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it excludes patients who are regularly treated with opioids or NSAIDs (non-steroidal anti-inflammatory drugs). This suggests that if you are on these medications regularly, you may not be eligible to participate.
What is the safety track record for these treatments?
Research shows that both treatment options under study—acetaminophen with ibuprofen and hydrocodone with acetaminophen and ibuprofen—are generally safe when used correctly.
Studies have shown that the combination of acetaminophen and ibuprofen is effective and well-tolerated for managing pain after surgery for certain fractures. Research found that this combination works as well as stronger painkillers in children, without the risk of addiction or severe side effects.
Studies suggest that hydrocodone combined with acetaminophen and ibuprofen is also effective for pain relief. However, it carries a higher risk of side effects like drowsiness and potential for misuse because it includes an opioid, a strong painkiller that can be addictive.
Both treatments should be used as directed to avoid problems. For instance, excessive acetaminophen over time can harm the liver. Following dosing instructions carefully for all medications is crucial to ensure safety.12345Why are researchers enthusiastic about this study treatment?
Most treatments for supracondylar humerus fractures traditionally involve opioids like hydrocodone combined with acetaminophen to manage pain. But researchers are excited about using a non-opioid approach that combines acetaminophen with ibuprofen instead. This alternative is unique because it avoids opioids, reducing the risk of addiction and side effects associated with opioid use. Additionally, the combination of acetaminophen and ibuprofen can offer effective pain relief without the sedation often linked with opioids, making it a potentially safer option for managing pain in patients.
What evidence suggests that this trial's treatments could be effective for supracondylar humerus fractures?
This trial will compare opioid and non-opioid pain management strategies for supracondylar humerus fractures. Research has shown that non-opioid pain relievers, such as a combination of acetaminophen and ibuprofen, can ease pain in children after elbow fracture surgery as effectively as opioids. Participants in the non-opioid group will receive acetaminophen and ibuprofen, which studies have found effectively manage pain, with noticeable improvement by the fifth day after surgery. The control group will receive hydrocodone with acetaminophen and ibuprofen, which also provides effective pain relief but does not surpass non-opioid options. Both methods offer good pain relief, but non-opioids are safer due to fewer risks, such as addiction.26789
Are You a Good Fit for This Trial?
This trial is for individuals who have undergone surgery to fix a type of broken arm known as Gartland Type III supracondylar humerus fractures. The study aims to find the best pain management after surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either nonopioid or opioid analgesic regimens following surgical fixation of Gartland Type III supracondylar humerus fractures
Follow-up
Participants are monitored for safety and effectiveness after treatment, with pain levels and parent satisfaction assessed
What Are the Treatments Tested in This Trial?
Interventions
- Acetaminophen
- Hydrocodone/acetaminophen
- Ibuprofen
Acetaminophen is already approved in United States, European Union, Canada for the following indications:
- Pain relief
- Fever reduction
- Pain relief
- Fever reduction
- Pain relief
- Fever reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Mercy Hospital Kansas City
Lead Sponsor